-
Rohit and Rickelton power Mumbai to IPL win over Kolkata
-
Russian tanker nears Cuba, defying US oil blockade
-
'Project Hail Mary' tops N. America box office for second week
-
Forty new migratory species win international protection: UN body
-
Freed whale gets stranded again on German coast
-
Ter Stegen's World Cup chances 'very slim', says Nagelsmann
-
Pakistan hosts Saudi, Turkey, Egypt for talks on Mideast war
-
Tudor leaves after just seven games as Spurs battle for survival
-
Philipsen sprints to In Flanders Fields victory
-
In Israel, air raid sirens spark anxiety and dilemmas
-
Iran accuses US of plotting ground attack despite diplomatic talk
-
Vingegaard clinches Tour of Catalonia victory
-
Despondent Verstappen questions Formula One future
-
Two more arrests over attempted attack on US bank HQ in Paris
-
Nepal's ex-PM attends court hearing in protest crackdown case
-
Iran parliament speaker says US planning ground attack
-
Despondent Verstappen says Red Bull woes 'not sustainable'
-
Piastri says Japan second place 'as good as a win' for McLaren
-
Nepal's former energy minister arrested in graft probe
-
IOC reinstating gender tests 'a disrespect for women' - Semenya
-
Youngest F1 title leader Antonelli to keep 'raising bar' after Japan win
-
High hopes at China's gateway to North Korea as trains resume
-
Antonelli wins in Japan to become youngest F1 championship leader
-
Mercedes' Antonelli wins Japanese Grand Prix to take lead
-
Germany's WWII munitions a toxic legacy on Baltic Sea floor
-
Iran claims aluminium plant attacks in Gulf as Houthis join war
-
North Korea's Kim oversees test of high-thrust engine: state media
-
Five Apple anecdotes as iPhone maker marks 50 years
-
'Excited' Buttler rejuvenated for IPL after horror T20 World Cup
-
Ship insurers juggle war risks for perilous Gulf route
-
Helplines buzz with alerts from seafarers trapped in war
-
Let's get physical: Singapore's seniors turn to parkour
-
Indian tile makers feel heat of Mideast war energy crunch
-
At 50, Apple confronts its next big challenge: AI
-
Houthis missile attacks on Israel widen Middle East war
-
Massive protests against Trump across US on 'No Kings' day
-
Struggling Force lament missed opportunities after Chiefs defeat
-
US thrashed 5-2 by Belgium in reality check for World Cup hosts
-
A Bright New Era in Electric Mobility - Accelerating the Future of Energy
-
China Xlx Announces 2025 Annual Results Deepening Efforts in Reducing Costs, Enhancing Efficiency, Strengthening Competitiveness Through Differentiation and Driving Marketing Transformation
-
Lakers guard Doncic gets one-game ban for accumulated technicals
-
Houthis claim missile attacks on Israel, entering Middle East war
-
NBA Spurs stretch win streak to eight in rout of Bucks
-
US lose 5-2 to Belgium in rude awakening for World Cup hosts
-
Sabalenka sinks Gauff to win second straight Miami Open title
-
Lebanon kids struggle to keep up studies as war slams school doors shut
-
Cherry blossoms, kite-flying and 'No Kings' converge on Washington
-
Britain's Kerr to target El Guerrouj's mile world record
-
Sailboats carrying aid reach Cuba after going missing: AFP journalist
-
Pakistan to host Saudi, Turkey, Egypt for talks on Mideast war
Trump announces drug prices cut with swipe at Europe
US President Donald Trump said Monday he would slash drug prices so that they match costs abroad, accusing the "brutal" European Union in particular of forcing pharmaceutical firms to lower prices on its turf.
Trump claimed as he signed the executive order at the White House that drug prices should fall by at least 59 percent -- and in some cases as high as 80 or 90 percent.
Under the plan, Trump aims to institute a "Most Favored Nation" policy that pins the cost of drugs sold in the United States to the lowest price paid by other countries for the same drug.
"Whoever is paying the lowest price, that's the price that we're going to get," Trump said.
The US president's plan will count mainly on the goodwill of pharmaceutical companies to negotiate their prices and could face legal challenges, as did a similar proposal Trump pushed during his first term.
Trump said American consumers had been treated like "suckers" and cited in particular the costs of the obesity-reducing drug Ozempic, which he said were vastly higher in Europe.
He blasted the European Union nation in particular over drug prices, alleging that the 27-nation bloc forced pharmaceutical firms to lower their costs on their territory.
"It was really the countries that forced Big Pharma to do things that, frankly, I'm not sure they really felt comfortable doing, but they've gotten away with it," Trump said.
"The European Union has been brutal, brutal. And the drug companies actually told me stories it was just brutal, how they forced them."
- 'Powerful lobby' -
Trump said he would also order an investigation into countries that "extort" drug companies by "blocking their products" unless they accepted low prices.
But Trump added that he was also "doing this against the most powerful lobby in the world -- the drug and pharmaceutical lobby."
Health Secretary Robert Kennedy Jr, who has caused controversy for his skepticism over vaccinations, praised the plan.
"There has never been a president more willing to stand up to the oligarchs than Donald Trump," Kennedy said as he stood next to the billionaire property developer.
Trump had trailed the announcement of the 59 percent cut earlier on Monday.
"DRUG PRICES TO BE CUT BY 59%, PLUS! Gasoline, Energy, Groceries, and all other costs, DOWN. NO INFLATION!!!" Trump posted on his Truth Social platform.
The reduction in prescription drug costs in the United States would, he added in his post, be counterbalanced by higher costs in other countries.
"Most favored nation" status is a World Trade Organization rule that aims to prevent discrimination between a country and its trading partners, levelling the playing field for international trade.
This is not the first time that Trump has attempted to lower US drug prices.
During his first 2017-2021 term in office, he announced a similar proposal to cut US drug prices but his plans failed in the face of strong opposition from the pharmaceutical industry.
Last month, the US president signed an executive order aiming to lower crippling drug prices by giving states more leeway to bargain-hunt abroad and improving the process for price negotiations.
T.Wright--AT